MeSH term
Frequency | Condition_Probility | Chromosome Mapping | 4 | 0.0 |
*Chromosomes, Human, Pair 1 | 2 | 0.0 |
DNA Mutational Analysis | 2 | 0.0 |
Extracellular Matrix Proteins/*genetics | 5 | 6.0 |
Humans | 18 | 0.0 |
Lipoidproteinosis/*genetics/pathology | 2 | 100.0 |
Research Support, Non-U.S. Gov't | 16 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 3 | 0.0 |
Sequence Analysis, DNA | 3 | 0.0 |
South Africa | 2 | 1.0 |
Adult | 5 | 0.0 |
Autoantibodies/*blood | 2 | 0.0 |
Extracellular Matrix Proteins/*immunology | 2 | 33.0 |
Female | 5 | 0.0 |
Lichen Sclerosus et Atrophicus/*immunology | 2 | 50.0 |
Middle Aged | 3 | 0.0 |
Adolescent | 2 | 0.0 |
Child | 2 | 0.0 |
Exons/genetics | 3 | 0.0 |
Haplotypes | 2 | 0.0 |
Homozygote | 2 | 0.0 |
Male | 3 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 3 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 3 | 0.0 |
Tumor Cells, Cultured | 2 | 0.0 |
Animals | 6 | 0.0 |
Mice | 5 | 0.0 |
RNA, Messenger/metabolism | 2 | 0.0 |
Immunoblotting | 2 | 0.0 |
Base Sequence | 3 | 0.0 |
Cloning, Molecular | 2 | 0.0 |
Molecular Sequence Data | 4 | 0.0 |
Amino Acid Sequence | 3 | 0.0 |
Chromosomes, Human, Pair 1/*genetics | 2 | 0.0 |
Cell Division | 2 | 0.0 |